微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | -2.35% | -92.62% | 84.46% | 39/44 | 1.64% | 澳洋健康 | 34.16% | 行业排名> |
| 2021-12-31 | -15.12% | -53.19% | -321.17% | 36/44 | -22.5% | 澳洋健康 | 30.56% | 行业排名> |
| 2021-09-30 | -3.59% | 54.96% | -13.25% | 35/44 | -16.31% | 澳洋健康 | 28.14% | 行业排名> |
| 2021-06-30 | -3.17% | 43.49% | -159.84% | 37/44 | -2.71% | 澳洋健康 | 39.54% | 行业排名> |
| 2021-03-31 | -1.22% | 51% | 87.64% | 29/44 | 0.51% | 澳洋健康 | 61.84% | 行业排名> |
| 2020-12-31 | -9.87% | 13.5% | -23.84% | 37/44 | 10.68% | 澳洋健康 | 48.34% | 行业排名> |
| 2020-09-30 | -7.97% | 6.01% | -42.07% | 28/44 | 9.96% | 澳洋健康 | 58.19% | 行业排名> |
| 2020-06-30 | -5.61% | -6.25% | -125.3% | 31/44 | 1.61% | *ST宜康 | 75.53% | 行业排名> |
| 2020-03-31 | -2.49% | -51.83% | 78.18% | 26/44 | 0.78% | 博腾股份 | 39.77% | 行业排名> |
| 2019-12-31 | -11.41% | 14.34% | -34.55% | 33/44 | 66.13% | 睿智医药 | 41.16% | 行业排名> |
| 2019-09-30 | -8.48% | -494.42% | -60.61% | 30/44 | 11.69% | 澳洋健康 | 51.68% | 行业排名> |
| 2019-06-30 | -5.28% | 19.76% | -221.95% | 30/44 | 4.42% | 澳洋健康 | 40.93% | 行业排名> |
| 2019-03-31 | -1.64% | -281.4% | 87.69% | 27/44 | 2.29% | 金域医学 | 43.58% | 行业排名> |
| 2018-12-31 | -13.32% | -64.44% | -719.53% | 33/44 | -13.84% | 金域医学 | 35.41% | 行业排名> |
| 2018-09-30 | 2.15% | 135.6% | 132.67% | 22/44 | 2.06% | 阳光诺和 | 26.2% | 行业排名> |
| 2018-06-30 | -6.58% | -157.03% | -1430.23% | 29/44 | 0.32% | 金域医学 | 13.23% | 行业排名> |
| 2018-03-31 | -0.43% | 94.71% | 94.69% | 23/44 | 0.05% | 万邦医药 | 52.05% | 行业排名> |
| 2017-12-31 | -8.1% | 81.12% | -34.11% | 34/44 | -2.22% | 华大基因 | 48.52% | 行业排名> |
| 2017-09-30 | -6.04% | 24.78% | -135.94% | 23/44 | 4.94% | 华大基因 | 31.24% | 行业排名> |
| 2017-06-30 | -2.56% | 92.79% | 68.51% | 27/44 | 61.39% | 阳光诺和 | 13.99% | 行业排名> |
| 2017-03-31 | -8.13% | -20225% | 81.05% | 21/44 | -6.8% | 南华生物 | 2848.07% | 行业排名> |
| 2016-12-31 | -42.9% | -50.42% | -434.25% | 29/44 | -7.78% | 南华生物 | 98.98% | 行业排名> |
| 2016-09-30 | -8.03% | -267.99% | 77.38% | 20/44 | 3.24% | 南华生物 | 82.46% | 行业排名> |
| 2016-06-30 | -35.5% | -590.66% | -88650% | 24/44 | 1.29% | 南华生物 | 48.41% | 行业排名> |
| 2016-03-31 | -0.04% | -100.59% | 99.86% | 17/44 | 2.38% | 万邦医药 | 106.72% | 行业排名> |
| 2015-12-31 | -28.52% | -118.88% | -696.65% | 26/44 | 10.75% | 国际医学 | 46.66% | 行业排名> |
| 2015-09-30 | 4.78% | 150% | 193% | 13/44 | 0.92% | 普蕊斯 | 22.99% | 行业排名> |
| 2015-06-30 | -5.14% | 19.31% | -176.15% | 18/44 | -34.33% | 通策医疗 | 6.02% | 行业排名> |
| 2015-03-31 | 6.75% | 303.93% | 151.8% | 1/44 | -6.39% | 普蕊斯 | 58.68% | 行业排名> |
| 2014-12-31 | -13.03% | 17.9% | -36.3% | 21/44 | -20.38% | -- | -- | 行业排名> |
| 2014-09-30 | -9.56% | -293.52% | -50.08% | 18/44 | -106.19% | -- | -- | 行业排名> |
| 2014-06-30 | -6.37% | 20.97% | -92.45% | 18/44 | -87.18% | -- | -- | 行业排名> |
| 2014-03-31 | -3.31% | 24.94% | 79.14% | 17/44 | -7.8% | -- | -- | 行业排名> |
| 2013-12-31 | -15.87% | 7.08% | -421.26% | 22/44 | 5.95% | -- | -- | 行业排名> |
| 2013-09-30 | 4.94% | 157.04% | 161.29% | 11/44 | 6.36% | -- | -- | 行业排名> |
| 2013-06-30 | -8.06% | -37.07% | -82.77% | 17/44 | 6.56% | -- | -- | 行业排名> |
| 2013-03-31 | -4.41% | -48.99% | 74.18% | 16/44 | 1.19% | -- | -- | 行业排名> |
| 2012-12-31 | -17.08% | -315.57% | -97.23% | 22/44 | -2.44% | -- | -- | 行业排名> |
| 2012-09-30 | -8.66% | 2% | -47.28% | 17/44 | 5.34% | -- | -- | 行业排名> |
| 2012-06-30 | -5.88% | 2% | -98.65% | 17/44 | 3.64% | -- | -- | 行业排名> |
| 2012-03-31 | -2.96% | 2% | 27.98% | 16/44 | 1.32% | -- | -- | 行业排名> |